
    
      For both parts of this study, on Day 1 of each period, participants will receive a single
      oral dose of danicopan as either the prototype powder-in-capsule (PIC) formulation (1 or 2)
      under fed conditions, the prototype PIC formulation (1 or 2) under fasting conditions, or the
      tablet formulation under fed conditions.
    
  